DOI: 10.12890/2025_005679
Anti-N-methyl-D-aspartate receptor encephalitis presenting as isolated first-episode psychosis in a 16-year-old girl, complicated by neuroleptic malignant syndrome
Authors
drghyzlane@gmail.com
Keywords
Anti-N-methyl-D-aspartate receptor encephalitis, first-episode psychosis, neuroleptic malignant syndrome, adolescentAbstract
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare but increasingly recognized autoimmune disorder that predominantly affects adolescents and young adults. It often presents with prominent psychiatric symptoms at onset, leading to frequent misdiagnosis as a primary psychiatric disorder.
We report the case of a 16-year-old girl who presented with acute psychiatric symptoms, including mood lability, hallucinations, and aggression, initially diagnosed as first-episode psychosis. Her condition rapidly deteriorated under antipsychotic treatment, progressing to neuroleptic malignant syndrome, followed by the emergence of cerebellar ataxia, which raised strong suspicion of an underlying organic aetiology. Subsequent investigations confirmed the diagnosis of anti-NMDAR encephalitis. The patient was successfully treated with intravenous immunoglobulin, achieving complete recovery.
This case underscores the diagnostic challenges posed by isolated psychiatric presentations of anti-NMDAR encephalitis in adolescents. Early recognition and prompt initiation of immunotherapy are crucial for favourable outcomes, particularly in cases presenting with antipsychotic intolerance or atypical clinical progression.
References
- Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36. doi: 10.1002/ana.21050
- Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 2013;70:1133-1139. doi: 10.1001/jamaneurol.2013.3216
- Sarmiento RJC, Diestro JDB, Antonio AKD, Prado MB, Adiao KJB, Dioquino-Maligaso CP. Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature. Neurohospitalist 2022;12:80-85. doi: 10.1177/19418744211002978
- Ramirez-Bermudez J, Restrepo-Martinez M, Espinola-Nadurille M, Martinez-Angeles V, Lopez-Hernandez JC, Hernandez-Vanegas LE, et al. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study. J Acad Consult Liaison Psychiatry 2024;65:222-230. doi: 10.1016/j.jaclp.2023.12.002
- Li Y, Luo H, Zheng Y, Zhou L, Jiang Y, Li X, Ma J, et al. Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study. Mult Scler Relat Disord 2023;80:105063. doi: 10.1016/j.msard.2023.105063
- Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, et al. Anti-NMDAR encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011;199:508-509. doi: 10.1192/bjp.bp.111.092197
- Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, et al. Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm 2016;3:e280. doi: 10.1212/NXI.0000000000000280
- Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012;79:1094-1100. doi: 10.1212/WNL.0b013e3182698cd8
- Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014;13:167-177. doi: 10.1016/S1474-4422(13)70282-5
- Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015;15:1391-1419. doi: 10.1586/14737175.2015.1115720